Cantor Fitzgerald Reiterates Overweight on Mesoblast, Maintains $17 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Mesoblast (NASDAQ:MESO) and maintained a $17 price target.
September 21, 2023 | 12:58 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated an Overweight rating on Mesoblast, maintaining a $17 price target.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Mesoblast. The maintained price target of $17 suggests that the analyst believes the stock is undervalued at current levels, which could lead to upward price movement in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100